Literature DB >> 3592985

Removal of nonspecific hemagglutination inhibitors, immunoglobulin G, and immunoglobulin A with streptococcal cells and its application to the rubella hemagglutination inhibition test.

K Kawano, Y Minamishima.   

Abstract

A streptococcus, AW 43 strain, was found to bind nonspecific serum inhibitors of rubella virus hemagglutination (HA). This was demonstrated by titration of nonspecific HA inhibitors and by immunoelectrophoresis. Absorption of sera with the mixture of AW 43 cells, which bind IgA in addition to nonspecific HA inhibitors, and AR 1 cells, another strain of streptococci which bind IgG, removed nonspecific HA inhibitors, IgG, and IgA simultaneously, leaving behind IgM and a trace of IgA. Pretreatment of sera with those streptococcal cells prior to the rubella hemagglutination inhibition (HI) test enabled to circumvent kaolin treatment of sera, which partially removes IgM antibodies, and to determine exclusively the early-appearing antibodies. The rise and fall of the HI antibodies thus determined correlated well with that of the IgM antibodies determined by enzyme-linked immunosorbent assay (ELISA). Thus, this modified rubella HI test may be useful for serodiagnosis of recent rubella virus infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592985     DOI: 10.1007/bf01311333

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Modified staphylococcal absorption method used for detecting rubella-specific immunoglobin M antibodies during a rubella epidemic.

Authors:  R Handsher; A Fogel
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

2.  Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses.

Authors:  K F Shortridge; W K Ho
Journal:  J Gen Virol       Date:  1974-04       Impact factor: 3.891

3.  Detection of early hemagglutination inhibitory antibodies to rubella virus by pretreatment of sera with streptococcal cells.

Authors:  K Kawano; S Yamamoto; Y Minamishima
Journal:  J Med Virol       Date:  1986-06       Impact factor: 2.327

4.  Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

5.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

6.  Binding of IgA to protein-A-containing staphylococci: relationship to subclasses.

Authors:  E Saltvedt; M Harboe
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

8.  Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodies.

Authors:  D B Budzko; D F Jelinek; B W Wilcke
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

9.  Variables of the rubella hemagglutination-inhibition test system and their effect on antigen and antibody titers.

Authors:  N J Schmidt; E H Lennette
Journal:  Appl Microbiol       Date:  1970-03

10.  Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci.

Authors:  G Kronvall; A Simmons; E B Myhre; S Jonsson
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  1 in total

1.  Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum.

Authors:  K Kondo; Y Hayakawa; H Mori; S Sato; T Kondo; K Takahashi; Y Minamishima; M Takahashi; K Yamanishi
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.